Epigral Ltd vs Tgv Sraac Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Epigral Ltd is ₹ 856.9 as of 18 Mar 14:04 . The P/E Ratio of Epigral Ltd changed from 16 on March 2022 to 22.9 on March 2025 . This represents a CAGR of 9.38% over 4 yearsThe P/E Ratio of TGV Sraac Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Epigral Ltd changed from ₹ 4045 crore on March 2022 to ₹ 8191 crore on March 2025 . This represents a CAGR of 19.29% over 4 yearsThe Market Cap of TGV Sraac Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Epigral Ltd for the Dec '25 is ₹ 602.68 crore as compare to the Sep '25 revenue of ₹ 589.1 crore. This represent the growth of 2.31% The revenue of TGV Sraac Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Epigral Ltd for the Dec '25 is ₹ 108.26 crore as compare to the Sep '25 ebitda of ₹ 133.8 crore. This represent the decline of -19.09% The ebitda of TGV Sraac Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Epigral Ltd changed from ₹ 85.87 crore to ₹ 39.11 crore over 7 quarters. This represents a CAGR of -36.20% The net profit of TGV Sraac Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Epigral Ltd changed from 5.88 % on March 2023 to 7.26 % on March 2025 . This represents a CAGR of 7.28% over 3 yearsThe Dividend Payout of TGV Sraac Ltd changed from 2.96 % on March 2023 to 11.63 % on March 2025 . This represents a CAGR of 57.80% over 3 years .

About Epigral Ltd

Epigral Limited was erstwhile incorporated as 'Meghmani Finechem Limited' in 2007, which is engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products.
The Company was incorporated as a subsidiary of Meghmani Organics Limited. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern, through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021.
The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21.
The Company is now among the leading players in India's chlor alkali industry.
In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited.

About TGV Sraac Ltd

TGV Sraac Limited, formerly known as Sree Rayalaseema Alkali and Allied Chemicals Limited was incorporated on 24th June, 1981.
The name of Company was changed from 'Sree Rayalaseema Alkali and Allied Chemicals Limited' to 'TGV Sraac Limited' in September, 2017.
Company is the leading producer of Chlor'Alkali Chemicals, Chloromethanes and also manufactures Castor Derivatives and Fatty Acids.
It manufactures Caustic Soda, Liquid Chlorine, Hydrochloric Acid, Hydrogen and Barium Sulphate. The company started commercial production in Aug.'88 with an initial installed capacity of 22,440 tpa of caustic soda.
Presently the company has the capacity to produce 69500 TPA of caustic soda The company uses Bipolar Membrane Cell Technology, the latest one in the world for the manufacture of caustic soda and allied products.

FAQs for the comparison of Epigral Ltd and TGV Sraac Ltd

Which company has a larger market capitalization, Epigral Ltd or TGV Sraac Ltd?

Market cap of Epigral Ltd is 3,685 Cr while Market cap of TGV Sraac Ltd is 867 Cr

What are the key factors driving the stock performance of Epigral Ltd and TGV Sraac Ltd?

The stock performance of Epigral Ltd and TGV Sraac Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Epigral Ltd and TGV Sraac Ltd?

As of March 18, 2026, the Epigral Ltd stock price is INR ₹854.2. On the other hand, TGV Sraac Ltd stock price is INR ₹80.99.

How do dividend payouts of Epigral Ltd and TGV Sraac Ltd compare?

To compare the dividend payouts of Epigral Ltd and TGV Sraac Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.